Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 3, 2021 2:30 PM 4 min read

Mid-Afternoon Market Update: Nasdaq Falls Over 300 Points; Veritiv Shares Surge

by Lisa Levin Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

Toward the end of trading Wednesday, the Dow traded up 0.10% to 31,422.79 while the NASDAQ fell 2.51% to 13,023.43. The S&P also fell, dropping 0.82% to 3,838.38.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 28,664,600 cases with around 514,660 deaths. India confirmed a total of at least 11,124,520 confirmed cases and 157,240 deaths, while Brazil reported over 10,587,000 COVID-19 cases with 255,720 deaths. In total, there were at least 114,499,550 cases of COVID-19 worldwide with over 2,540,340 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Energy shares rose 2.6% on Wednesday. Meanwhile, top gainers in the sector included The Callon Petroleum Company (NYSE:CPE), up 17%, and Centennial Resource Development, Inc. (NASDAQ:CDEV), up 13%.


In trading on Wednesday, information technology shares fell 2.1%.


Top Headline

Dollar Tree, Inc. (NASDAQ:DLTR) reported better-than-expected earnings for its fourth quarter, while sales missed views.

Dollar Tree posted quarterly adjusted earnings of $2.13 per share, beating analysts’ estimates of $2.11 per share. The company reported sales of $6.77 billion, versus expectations of $6.79 billion.

Dollar Tree also added $2 billion to its buyback program.

 

Equities Trading UP


Cohen & Company Inc. (NASDAQ:COHN) shares shot up 110% to $36.90 after the company reported a strong rise in Q4 earnings and sales.


Veritiv Corporation (NYSE:VRTV) shares were also up, gaining 58% to $39.80 after the company reported an increase in Q4 earnings and announced a $50 million buyback plan.

Check out these big movers of the day


Equities Trading DOWN

Vir Biotechnology, Inc. (NASDAQ:VIR) shares tumbled 31% to $40.01. Vir Biotechnology and GlaxoSmithKline have provided an update on the VIR-7831 (GSK4182136) arm of NIH-sponsored ACTIV Program Phase 3 trial in hospitalized adults with COVID-19.

Shares of Rocket Companies, Inc. (NASDAQ:RKT) were down 31% to $28.83 after RBC Capital downgraded the stock from Outperform to Sector Perform and announced a price target of $30 per share.

MICT, Inc. (NASDAQ:MICT) was down, falling 21% to $2.3250 after the company priced its 19.29 million share common stock and warrants offering.


Commodities


In commodity news, oil traded up 3.1% to $61.61, while gold traded down 0.9% to $1,717.90


Silver traded down 1.8% Wednesday to $26.405 while copper fell 1.6% to $4.1535.


Euro zone

European shares closed mostly higher today. The eurozone’s STOXX 600 gained 0.05%, the Spanish Ibex Index fell 0.32% and the German DAX 30 gained 0.29%. Meanwhile, the French CAC 40 rose 0.35%, London’s FTSE 100 rose 0.93% and Italy’s FTSE MIB fell 0.16%.

Producer prices in the Eurozone rose 1.4% in January following a revised 0.9% increase in December, while composite PMI increased to 48.8 in February from 47.8 in the earlier month. UK composite PMI increase to 49.6 in February from 41.2 in the earlier month, while German composite PMI rose to 51.1 in February from 50.8 in January. The French government budget deficit increased to EUR 21.9 billion in January from EUR 20 billion in the year-ago month.


Economics


US private businesses hired 117,000 workers in February following a revised 195,000 rise in the previous month.


The IHS Markit composite PMI increased to 59.5 in February from a preliminary estimate of 58.8.


The ISM services PMI fell to 55.3 in February from 58.7 in January.


US crude oil supplies climbed 21.563 million barrels last week, the Energy Information Administration said.


The Federal Open Market Committee released its latest Beige Book report.


Federal Reserve Bank of Dallas President Robert Kaplan will speak at 6:05 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Afternoon Market Update
COHN Logo
COHNCohen & Co Inc
$16.75-6.89%
Overview
DLTR Logo
DLTRDollar Tree Inc
$111.720.02%
RKT Logo
RKTRocket Companies Inc
$14.590.07%
VIR Logo
VIRVir Biotechnology Inc
$9.35-1.37%


Shares of KemPharm, Inc. (NASDAQ:KMPH) got a boost, shooting 44% to $13.57 after the company announced that FDA has approved the new drug application for Azstarys, formerly referred to as KP415, a once-daily product for the treatment of attention deficit hyperactivity disorder in patients age six years and older. It contains serdexmethylphenidate, KemPharm's prodrug of d-methylphenidate.

COHN Logo
COHNCohen & Co Inc
$16.75-6.89%
Overview
DLTR Logo
DLTRDollar Tree Inc
$111.720.02%
RKT Logo
RKTRocket Companies Inc
$14.590.07%
VIR Logo
VIRVir Biotechnology Inc
$9.35-1.37%
Comments
Loading...